|
US4372977A
(en)
|
1977-05-31 |
1983-02-08 |
Block Drug Company, Inc. |
Polyoxethylene derivatives as antipruritic ectoparasiticide
|
|
US4855090A
(en)
|
1987-03-13 |
1989-08-08 |
Micro-Pak, Inc. |
Method of producing high aqueous volume multilamellar vesicles
|
|
MY103673A
(en)
|
1988-01-14 |
1993-08-28 |
Kao Corp |
Detergent composition
|
|
DE69425750T2
(de)
|
1993-07-28 |
2001-04-26 |
Pharmaderm Laboratories Ltd., Saskatoon |
Zweiphasige multilamellare lipidvesikel
|
|
US5853755A
(en)
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
FR2730928B1
(fr)
|
1995-02-23 |
1997-04-04 |
Oreal |
Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
|
|
US5993852A
(en)
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
|
EP2481401A1
(en)
|
1999-01-18 |
2012-08-01 |
LG Life Sciences, Ltd. |
Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
|
|
US6696424B1
(en)
|
1999-05-28 |
2004-02-24 |
Vical Incorporated |
Cytofectin dimers and methods of use thereof
|
|
WO2001030808A1
(en)
|
1999-10-27 |
2001-05-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor-ligand binding
|
|
WO2001035998A1
(en)
|
1999-11-12 |
2001-05-25 |
Pharmaderm Laboratories, Ltd. |
Compositions for transdermal and transmucosal administration of therapeutic agents
|
|
US6656499B1
(en)
|
1999-11-12 |
2003-12-02 |
Pharmaderm Laboratories, Ltd. |
Composition for transdermal and dermal administration of interferon-α
|
|
FR2816577B1
(fr)
|
2000-11-10 |
2003-03-21 |
Peguform France |
Ensemble pour vehicule comportant un pare-chocs et une piece de carrosserie
|
|
US20030083286A1
(en)
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
|
US20030119774A1
(en)
|
2001-09-25 |
2003-06-26 |
Marianna Foldvari |
Compositions and methods for stimulating an immune response
|
|
FR2846238B1
(fr)
|
2002-10-29 |
2006-06-23 |
Oreal |
Composition sous forme d'emulsion huile-dans-eau et ses utilisations notamment cosmetiques
|
|
US20040219232A1
(en)
*
|
2003-02-06 |
2004-11-04 |
Zengen, Inc. |
Methods and compounds for treating malabsorption diseases and inflammatory conditions of the gastrointestinal tract
|
|
ATE471340T1
(de)
*
|
2004-02-11 |
2010-07-15 |
Amylin Pharmaceuticals Inc |
Peptide der amylin familie, verfahren zu deren herstellung und verwendung
|
|
WO2006012414A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Novel polyadenylation signal for use in expression vectors
|
|
FR2876577B1
(fr)
|
2004-10-15 |
2007-02-02 |
Oreal |
Creme savon a l'alcool behenylique
|
|
EA013056B1
(ru)
|
2005-04-01 |
2010-02-26 |
Ньюроджесэкс, Инк. |
Масла капсаициноидов и способы их получения и применения
|
|
NZ565217A
(en)
*
|
2005-07-08 |
2010-03-26 |
Ipsen Pharma Sas |
Melanocortin receptor ligands
|
|
FR2892939B1
(fr)
|
2005-11-10 |
2010-01-22 |
Groupement Coeur Artificiel Total Carpentier Matra Carmat |
Materiau hemocompatible composite et son procede d'obtention
|
|
EP1955691A1
(en)
|
2005-11-24 |
2008-08-13 |
Shiseido Company, Limited |
External preparation for skin
|
|
KR100748035B1
(ko)
|
2006-02-22 |
2007-08-09 |
(주)아모레퍼시픽 |
비인지질 베지클로 포집된 유용성분을 함유하는 화장료조성물
|
|
AU2007233155B2
(en)
|
2006-03-29 |
2012-04-26 |
Scitech Development Llc |
Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
|
|
US20080008747A1
(en)
|
2006-07-07 |
2008-01-10 |
Royds Robert B |
Transdermal patch
|
|
FR2911280B1
(fr)
*
|
2007-01-16 |
2012-06-22 |
Mayoly Spindler Lab |
Association de composes inhibiteurs de la melanogenese et leurs utilisations en cosmetique et en dermatologie
|
|
WO2008119160A1
(en)
|
2007-03-30 |
2008-10-09 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
|
|
EP1985298A1
(en)
|
2007-04-24 |
2008-10-29 |
Azad Pharma AG |
Ophtalmic oil-in-water emulsions containing prostaglandins
|
|
FR2921253B1
(fr)
|
2007-09-26 |
2012-11-16 |
Lvmh Rech |
Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation
|
|
CA2998948A1
(en)
*
|
2008-05-27 |
2009-12-17 |
Genzyme Corporation |
Peptide analogs of alpha-melanocyte stimulating hormone
|
|
US20120014894A1
(en)
*
|
2008-12-31 |
2012-01-19 |
Revance Therapeutics, Inc. |
Compositions and Methods for Treating Hyperpigmentation
|
|
US8614185B2
(en)
*
|
2009-05-04 |
2013-12-24 |
Centocor Ortho Biotech Inc. |
Fusion proteins of alpha-MSH derivatives and Fc
|
|
UA111147C2
(uk)
|
2009-11-11 |
2016-04-11 |
Байєр Б.В. |
Способи та композиції для лікування або профілактики зовнішнього отиту
|
|
WO2012088414A1
(en)
*
|
2010-12-23 |
2012-06-28 |
Ludwig Institute For Cancer Research Ltd. |
Liposomal formulation of nonglycosidic ceramides and uses thereof
|
|
US10159646B2
(en)
|
2013-08-12 |
2018-12-25 |
Altum-Avro Pharma Partnership |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
|
US20160151283A1
(en)
|
2014-11-27 |
2016-06-02 |
Icnoderm S.R.L. |
Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process
|
|
SG10201506686WA
(en)
*
|
2015-08-24 |
2017-03-30 |
Agency Science Tech & Res |
Conjugates
|
|
ES3055492T3
(en)
|
2015-09-16 |
2026-02-12 |
Dfb Soria Llc |
Delivery of drug nanoparticles and methods of use thereof
|
|
US20170304232A1
(en)
|
2016-04-20 |
2017-10-26 |
Northwestern University |
Endoxifen For Local Transdermal Therapy To The Breast
|
|
US10324135B2
(en)
|
2016-06-06 |
2019-06-18 |
Mitsubishi Electric Research Laboratories, Inc. |
Methods and systems for data-driven battery state of charge (SoC) estimation
|
|
WO2018144093A2
(en)
|
2016-11-03 |
2018-08-09 |
Pinsky Mark A |
Formulations for improved skin care
|
|
US11117930B2
(en)
|
2017-02-23 |
2021-09-14 |
Adrx, Inc. |
Peptide inhibitors of transcription factor aggregation
|
|
US10251709B2
(en)
|
2017-03-05 |
2019-04-09 |
Samuel Cho |
Architecture, system, and method for developing and robotically performing a medical procedure activity
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|
|
US20180360757A1
(en)
|
2017-05-26 |
2018-12-20 |
Altum Pharmaceuticals Inc. |
Biphasix cannabinoid delivery
|
|
WO2019168163A1
(ja)
|
2018-03-02 |
2019-09-06 |
国立大学法人広島大学 |
形質転換体および当該形質転換体を用いた還元型リン化合物の有無の検出方法
|
|
CN108948151B
(zh)
*
|
2018-08-06 |
2019-06-21 |
山西锦波生物医药股份有限公司 |
肽及其制备方法和用途
|
|
EP3866828A4
(en)
|
2018-10-16 |
2022-08-31 |
GLO Pharma, Inc. |
Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
|
|
EP4034087A4
(en)
|
2019-09-23 |
2023-10-25 |
DDS Research Inc. |
LIPID VESICLE COMPOSITIONS USING PENETRATION ENHANCING AGENTS
|
|
US20230149560A1
(en)
|
2020-04-20 |
2023-05-18 |
Massachusetts Institute Of Technology |
Lipid compositions for delivery of sting agonist compounds and uses thereof
|
|
WO2022204305A2
(en)
|
2021-03-24 |
2022-09-29 |
Glo Pharma, Inc. |
Peptides and methods for reducing skin pigmentation
|
|
CA3212844A1
(en)
|
2021-03-24 |
2022-09-29 |
Marianna Foldvari |
Multisome lipid vesicles for delivery of cosmetic agents
|
|
AU2022245251A1
(en)
|
2021-03-24 |
2023-10-12 |
Glo Pharma, Inc. |
Multisome lipid vesicles for delivery of cosmetic agents
|
|
WO2022204309A1
(en)
|
2021-03-24 |
2022-09-29 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for tigit
|
|
KR20240102989A
(ko)
|
2021-11-04 |
2024-07-03 |
글로 파마, 인크. |
화장품 적용을 위한 방법 및 조성물
|